Xerium Technologies, Inc. (NYSE:XRM), a leading global manufacturer of
clothing and roll covers used primarily in the paper production process,
today reported results for its second quarter ended June 30, 2008.
“The transformation that we began in early
2008 is starting to show results,” said
Stephen Light, President, Chief Executive Officer and Chairman. “While
the market continues to remain challenging, we believe we have improved
our ability to compete effectively. We anticipate that most of the hard
work to restructure certain operations and execute an amended credit
agreement is now largely behind us. We’ve
begun to reduce working capital as Xerium’s
employees remain focused on delivering the results we expect in our new
business plan and paying down our debt.”
SECOND QUARTER FINANCIAL HIGHLIGHTS
For the second quarter 2008, compared to the second quarter 2007:
-
Net sales for the 2008 quarter were $170.4 million, a 10.9% increase
from net sales for the 2007 quarter of $153.7 million. Excluding the
currency effects shown in the table below, second quarter 2008 net
sales increased 2.8% from the second quarter of 2007, with a decline
of 1.8% and an increase of 12.2% in the clothing and roll covers
segments, respectively.
-
Gross margins were $68.8 million or 40.4% of net sales for the 2008
quarter, compared to $64.2 million or 41.8% of net sales for the 2007
quarter. Meanwhile, the Company believes it is now beginning to get
initial traction on its cost reduction initiatives to offset the
negative effects of pricing, currency, and cost inflation.
-
Income from operations declined by 25.9% to $17.7 million for the 2008
quarter from $23.9 million for the 2007 quarter. During the second
quarter of 2008, the Company expensed approximately $5.2 million to
general and administrative expenses in connection with the amendments
to its credit facility. In addition, for the second quarter of 2008,
restructuring and impairment expenses increased by $1.5 million to
$2.7 million from $1.2 million in the second quarter of 2007.
-
Net income increased 83.1% to $14.1 million or $0.31 per diluted share
for the 2008 quarter, compared to net income of $7.7 million or $0.17
per diluted share for the 2007 quarter. The increase in net income was
largely due to a $13.7 million pre-tax, non-cash credit to interest
expense reflecting the mark-to-market increase in the fair value of
the Company’s interest rate swaps (compared
to a $0.1 million such credit in the second quarter of 2007). Net
income was negatively affected by the $5.2 million pre-tax expense
previously noted in connection with amendments to the credit facility.
-
Net cash generated by operating activities was $11.2 million for the
2008 quarter, which compares to $14.8 million for the 2007 quarter.
Cash provided by operating activities was decreased by approximately
$4.4 million related to amendment costs in the second quarter of 2008.
The Company has reduced working capital from 30% of revenues in the
year-ago quarter to 27%.
-
Adjusted EBITDA (as defined in the Company’s
amended credit facility) was $50.2 million for the 2008 quarter,
compared to $38.2 million for the 2007 quarter. See “EBITDA
and Adjusted EBITDA Reconciliation” below.
-
In order to improve performance, the Company continues to target a
reduction in days of receivables and increases in inventory turns and
days of payables outstanding. During the 2008 quarter, as compared
with the 2007 quarter, the Company reported that accounts receivables,
as measured as a ratio of days of receivables, improved from 63 days
to 59 days, inventory turns improved to 3.4 versus 3.2 and days of
payables improved to 41 days versus 35 days.
-
Cash on hand at June 30, 2008 was $25.4 million, compared to cash on
hand at March 31, 2008 of $31.0 million. Cash on hand at June 30, 2007
was $24.7 million.
-
During the 2008 quarter, Xerium made senior debt principal repayments
of $2.3 million. During the six months ended June 30, 2008, the
Company made senior debt repayments of $13.5 million.
-
Capital expenditures during the 2008 quarter were $8.8 million,
compared to $7.3 million during the 2007 quarter. As previously
disclosed, the Company has slowed the pace of planned capital
expenditures for its Vietnam facility and does not expect to begin
production until 2009. The Company expects that capital expenditures
will be in a range of approximately $38 to $44 million in 2008, and
that capital expenditures in 2009 will be lower than those for 2008.
OTHER HIGHLIGHTS
-
As announced on May 30, the Company secured a fifth amendment to its
existing $700 million senior credit facility, which requires that the
Company comply with revised operating controls and financial
covenants. The term loan portion of the credit facility matures in
2012 and the revolving credit portion matures in 2011, which is
unchanged in the credit facility amendment.
-
On August 4, 2008, the Company’s
independent registered public accounting firm, Ernst & Young LLP,
removed the going concern explanatory paragraph from its audit report
on the Company's financial statements as of December 31, 2007 and 2006
and for each of the three years in the period ended December 31, 2007.
SEGMENT INFORMATION
The following table presents net sales for the second quarter of 2008
and 2007 by segment and the effect of currency on pricing and
translation on second quarter 2008 net sales:
(in millions):
|
|
|
Net Sales
Three Months Ended June 30,
|
|
Increase in net sales from Q2 2007 to Q2 2008
|
|
Increase in Q2 2008 net sales due to currency translation (a)
|
|
Percent increase (decrease) in net sales from Q2 2007 to
Q2 2008
|
|
|
|
|
|
|
|
2008
|
|
2007
|
|
|
|
Total
|
|
Excluding currency translation effect
|
|
(b) Change in
Q2 2008 net sales due to currency
effects on pricing
|
|
Percent increase (decrease) in net sales from Q2 2007 to Q2 2008
excluding effect of currency on pricing and translation
|
|
Clothing
|
|
$
|
109.3
|
|
$
|
102.9
|
|
$
|
6.4
|
|
$
|
11.3
|
|
6.2
|
%
|
|
(4.8
|
)%
|
|
$
|
(3.0
|
)
|
|
(1.8
|
)%
|
|
Roll Covers
|
|
|
61.1
|
|
|
50.8
|
|
|
10.3
|
|
|
4.1
|
|
20.3
|
%
|
|
12.2
|
%
|
|
|
-
|
|
|
12.2
|
%
|
|
Total
|
|
$
|
170.4
|
|
$
|
153.7
|
|
$
|
16.7
|
|
$
|
15.4
|
|
10.9
|
%
|
|
0.8
|
%
|
|
$
|
(3.0
|
)
|
|
2.8
|
%
|
|
|
|
(a) Increase in second quarter 2008 net sales due to currency
translation is calculated by subtracting (i) an amount equal to
net sales for the second quarter of 2007 from (ii) net sales for
the second quarter of 2007 at the applicable average foreign
currency exchange rate for the second quarter of 2008.
|
|
|
|
(b) Change in the second quarter 2008 net sales due to currency
effect on pricing relates to sales prices indexed in U.S. Dollars
by certain non-U.S. operations and is calculated based on the
difference in the exchange rate from the time of pricing
commitment to the customer and the point at which the sale
transaction is recorded.
|
CLOTHING SEGMENT HIGHLIGHTS
-
Clothing segment sales during the second quarter of 2008 increased
$6.4 million, or 6.2%, to $109.3 million, from $102.9 million in the
year-ago quarter, primarily from the favorable currency effects of
$8.3 million and increased sales in Asia-Pacific, partially offset by
decreased sales in North America and Europe. Net sales excluding the
effects of currency decreased approximately 1.8%.
-
Overall pricing levels in the clothing segment decreased approximately
1% during the 2008 quarter, compared to the prior-year period.
-
Clothing segment earnings for the quarter increased 6.1% to $27.9
million for the 2008 quarter, compared to the prior-year quarter.
ROLL COVERS SEGMENT HIGHLIGHTS
-
Roll covers segment sales during the 2008 quarter increased $10.3
million, or 20.3%, to $61.1 million from $50.8 million in the 2007
quarter, due to $4.1 million of favorable currency effects on non-U.S.
Dollar sales and increased sales in Europe, North America and
Asia-Pacific.
-
Overall pricing levels in the roll covers segment decreased by less
than 1% in the 2008 quarter, compared to the prior year period.
-
Roll covers segment earnings for the quarter increased 9.2% to $15.5
million for the 2008 quarter, compared to the prior-year quarter.
CONFERENCE CALL
The Company plans to hold a conference call to discuss these results
tomorrow morning:
Date: Thursday, August 7, 2008
Start Time: 8:00 a.m. EDT
Domestic Dial-In: +1-800-706-7741
International Dial-In: +1-617-614-3471
Passcode: 32137232
To participate on the call, please dial in at least 10 minutes prior to
the scheduled start.
NON-GAAP FINANCIAL MEASURES
Adjusted EBITDA and EBITDA are not measures of performance under
generally accepted accounting principles (“GAAP”);
they are non-GAAP financial measures. Xerium Technologies uses these
measures as supplementary non-GAAP financial measures to assist in
evaluating liquidity and financial performance, specifically in
evaluating the Company's ability to service indebtedness and to fund
ongoing capital expenditures. Xerium Technologies' credit facility
includes covenants based upon Adjusted EBITDA. If Adjusted EBITDA
declines below certain levels, the Company could go into default under
the credit facility or be required to prepay the credit facility.
Neither Adjusted EBITDA nor EBITDA should be considered in isolation or
as a substitute for net cash provided by operating activities (as
determined in accordance with GAAP) or income from operations (as
determined in accordance with GAAP). For additional information
regarding Adjusted EBITDA and EBITDA, and a reconciliation of such
measures to the most comparable financial measures under GAAP, please
see below. The information in this press release should be read in
conjunction with the financial statements and footnotes contained in our
documents to be filed with the Securities and Exchange Commission.
About Xerium Technologies
Xerium Technologies, Inc. (NYSE:XRM) is a leading global manufacturer
and supplier of two types of consumable products used primarily in the
production of paper: clothing and roll covers. The Company, which
operates around the world under a variety of brand names, utilizes a
broad portfolio of patented and proprietary technologies to provide
customers with tailored solutions and products integral to production,
all designed to optimize performance and reduce operational costs. With
35 manufacturing facilities in 15 countries around the world, Xerium has
approximately 3,700 employees.
FORWARD-LOOKING STATEMENTS
This press contains forward-looking statements. These statements relate
to future events or to our future financial performance and involve
known and unknown risks, uncertainties, and other factors that may cause
actual results, levels of activity, performance, or achievements to be
materially different from any future results, levels of activity,
performance, or achievements expressed or implied by these
forward-looking statements. In some cases, forward-looking statements
can be identified by the use of words such as “may,”
“could,” “expect,”
“intend,” “plan,”
“seek,” “anticipate,”
“believe,” “estimate,”
“predict,” “potential,”
or “continue” or
the negative of these terms or other comparable terminology. Undue
reliance should not be placed on forward-looking statements because they
involve known and unknown risks, uncertainties, and other factors that
are, in some cases, beyond our control and that could materially affect
actual results, levels of activity, performance, or achievements.
Factors that could materially affect our actual results, levels of
activity, performance or achievements include the following items: (i)
our revenues and profitability could be adversely affected by
fluctuations in currency exchange rates; (ii) our profitability would be
reduced by a decline in the prices of our products; (iii) our
profitability could be adversely affected by fluctuations in interest
rates; (iv) we may not be able to develop and market new products
successfully or we may not be successful in competing against new
technologies developed by competitors; (v) our credit facility contains
restrictive covenants, including covenants requiring compliance with
minimum interest coverage and fixed charge coverage ratios and maximum
leverage ratios, that will require us to improve our performance over
time in order to comply therewith; (vi) we may have insufficient cash to
fund growth and unexpected cash needs after satisfying our debt service
obligations due to our high degree of leverage and significant debt
service obligations; (vii) we are subject to the risk of weaker economic
conditions, including without limitation those affecting the paper
industry, in the locations around the world where we conduct business,
including current turmoil in the credit markets; (viii) we may be
required to incur significant costs to reorganize our operations in
response to market changes in the paper industry; (ix) we are subject to
the risk of terrorist attacks or an outbreak or escalation of any
insurrection or armed conflict involving the United States or any other
country in which we conduct business, or any other national or
international calamity; (x) we are subject to any future changes in
government regulation; (xi) we are subject to any changes in U.S. or
foreign government policies, laws and practices regarding the
repatriation of funds or taxes and (xii) those other risks described
under the heading "Risk Factors" in the Company's Annual Report on Form
10-K for the period ended December 31, 2007 filed with the Securities
and Exchange Commission and subsequent SEC filings. If any of these
risks or uncertainties materialize, or if our underlying assumptions
prove to be incorrect, actual results may vary significantly from what
we projected. Any forward-looking statement in this press release
reflects our current views with respect to future events and is subject
to these and other risks, uncertainties, and assumptions relating to our
operations, results of operations, growth strategy, and liquidity. We
assume no obligation to publicly update or revise these forward-looking
statements for any reason, whether as a result of new information,
future events, or otherwise.
|
Xerium Technologies, Inc.
|
|
Condensed Consolidated Balance Sheets--(Unaudited)
|
|
(dollars in thousands, except per share data)
|
|
|
|
|
|
June 30,
2008
|
December 31,
2007
|
|
ASSETS
|
|
|
|
Current assets:
|
|
|
|
Cash and cash equivalents
|
$
|
25,388
|
|
$
|
24,218
|
|
|
Accounts receivable (net of allowance for doubtful accounts of
$4,767 at June 30, 2008 and $5,367 at December 31, 2007)
|
|
110,126
|
|
|
113,256
|
|
|
Inventories
|
|
118,328
|
|
|
113,136
|
|
|
Prepaid expenses
|
|
9,683
|
|
|
6,287
|
|
|
Other current assets
|
|
20,908
|
|
|
29,441
|
|
|
Total current assets
|
|
284,433
|
|
|
286,338
|
|
|
Property and equipment, net
|
|
440,216
|
|
|
421,470
|
|
|
Goodwill
|
|
164,637
|
|
|
159,892
|
|
|
Intangible assets
|
|
36,778
|
|
|
17,381
|
|
|
Other assets
|
|
6,492
|
|
|
6,360
|
|
|
Total assets
|
$
|
932,556
|
|
$
|
891,441
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
(DEFICIT)
|
|
|
|
Current liabilities:
|
|
|
|
Notes payable
|
$
|
1,963
|
|
$
|
1,676
|
|
|
Accounts payable
|
|
46,102
|
|
|
44,842
|
|
|
Accrued expenses
|
|
75,742
|
|
|
61,070
|
|
|
Current maturities of long-term debt
|
|
17,970
|
|
|
19,253
|
|
|
Long-term debt classified as current
|
|
—
|
|
|
641,179
|
|
|
Total current liabilities
|
|
141,777
|
|
|
768,020
|
|
|
Long-term debt, net of current maturities and long-term debt
classified as current
|
|
650,267
|
|
|
4,693
|
|
|
Deferred and long-term taxes
|
|
21,327
|
|
|
23,114
|
|
|
Pension, other postretirement and postemployment obligations
|
|
92,460
|
|
|
90,749
|
|
|
Other long-term liabilities
|
|
6,030
|
|
|
5,917
|
|
|
Commitments and contingencies
|
|
|
|
Stockholders’ equity (deficit)
|
|
|
|
Preferred stock, $0.01 par value, 1,000,000 shares authorized; no
shares outstanding as of June 30, 2008 and December 31, 2007
|
|
—
|
|
|
—
|
|
|
Common stock, $0.01 par value, 150,000,000 shares authorized;
46,159,428 and 46,028,003 shares outstanding as of June 30, 2008 and
December 31, 2007, respectively
|
|
462
|
|
|
460
|
|
|
Paid-in capital
|
|
216,408
|
|
|
216,360
|
|
|
Accumulated deficit
|
|
(236,102
|
)
|
|
(245,511
|
)
|
|
Accumulated other comprehensive income
|
|
39,927
|
|
|
27,639
|
|
|
Total stockholders’ equity (deficit)
|
|
20,695
|
|
|
(1,052
|
)
|
|
Total liabilities and stockholders’
equity (deficit)
|
$
|
932,556
|
|
$
|
891,441
|
|
|
Xerium Technologies, Inc.
|
|
Condensed Consolidated Income Statements - (Unaudited)
|
|
(dollars in thousands, except per share data)
|
|
|
|
|
|
|
|
Three Months Ended
June 30,
|
|
Six Months Ended
June 30,
|
|
|
|
2008
|
|
|
|
2007
|
|
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
$
|
170,393
|
|
|
$
|
153,660
|
|
|
|
$
|
329,380
|
|
$
|
297,618
|
|
|
Costs and expenses:
|
|
|
|
|
|
|
|
|
Cost of products sold
|
|
101,595
|
|
|
|
89,482
|
|
|
|
|
197,250
|
|
|
172,662
|
|
|
Selling
|
|
21,847
|
|
|
|
19,938
|
|
|
|
|
42,312
|
|
|
39,391
|
|
|
General and administrative
|
|
23,367
|
|
|
|
16,433
|
|
|
|
|
42,057
|
|
|
34,046
|
|
|
Restructuring and impairments
|
|
2,718
|
|
|
|
1,220
|
|
|
|
|
3,250
|
|
|
5,353
|
|
|
Research and development
|
|
3,196
|
|
|
|
2,707
|
|
|
|
|
6,199
|
|
|
5,261
|
|
|
|
|
152,723
|
|
|
|
129,780
|
|
|
|
|
291,068
|
|
|
256,713
|
|
|
Income from operations
|
|
17,670
|
|
|
|
23,880
|
|
|
|
|
38,312
|
|
|
40,905
|
|
|
Interest expense
|
|
(1,135
|
)
|
|
|
(11,403
|
)
|
|
|
|
(26,550
|
)
|
|
(23,837
|
)
|
|
Interest income
|
|
369
|
|
|
|
248
|
|
|
|
|
563
|
|
|
495
|
|
|
Foreign exchange gain (loss)
|
|
(875
|
)
|
|
|
(443
|
)
|
|
|
|
2,634
|
|
|
(839
|
)
|
|
Income before provision for income taxes
|
|
16,029
|
|
|
|
12,282
|
|
|
|
|
14,959
|
|
|
16,724
|
|
|
Provision for income taxes
|
|
1,911
|
|
|
|
4,604
|
|
|
|
|
5,550
|
|
|
6,005
|
|
|
Net income
|
$
|
14,118
|
|
|
$
|
7,678
|
|
|
|
$
|
9,409
|
|
$
|
10,719
|
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
Basic
|
$
|
0.31
|
|
|
$
|
0.17
|
|
|
|
$
|
0.20
|
|
$
|
0.24
|
|
|
Diluted
|
$
|
0.31
|
|
|
$
|
0.17
|
|
|
|
$
|
0.20
|
|
$
|
0.24
|
|
|
Shares used in computing net income per share:
|
|
|
|
|
|
|
|
|
Basic
|
|
46,121,323
|
|
|
|
44,529,632
|
|
|
|
|
46,084,995
|
|
|
44,222,766
|
|
|
Diluted
|
|
46,211,012
|
|
|
|
44,624,036
|
|
|
|
|
46,189,813
|
|
|
44,345,551
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends per common share:
|
$
|
—
|
|
|
$
|
0.1125
|
|
|
|
$
|
—
|
|
$
|
0.3375
|
|
|
Xerium Technologies, Inc.
|
|
Condensed Consolidated Statements of Cash Flows - (Unaudited)
|
|
(dollars in thousands)
|
|
|
Six Months Ended
June 30,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
Operating activities
|
|
|
|
Net income
|
$
|
9,409
|
|
$
|
10,719
|
|
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
Stock-based compensation
|
|
274
|
|
|
1,195
|
|
|
Depreciation
|
|
22,152
|
|
|
20,005
|
|
|
Amortization of intangibles
|
|
1,807
|
|
|
2,224
|
|
|
Deferred financing cost amortization
|
|
2,344
|
|
|
1,818
|
|
|
Unrealized foreign exchange gain on revaluation of debt
|
|
(1,476
|
)
|
|
(1
|
)
|
|
Deferred taxes
|
|
(3,012
|
)
|
|
5,780
|
|
|
Asset impairment
|
|
67
|
|
|
389
|
|
|
Gain on disposition of property and equipment
|
|
(269
|
)
|
|
(1,145
|
)
|
|
Change in fair value of interest rate swaps
|
|
(1,548
|
)
|
|
1,494
|
|
|
Change in assets and liabilities which provided (used) cash:
|
|
|
|
Accounts receivable
|
|
7,571
|
|
|
7,049
|
|
|
Inventories
|
|
859
|
|
|
(5,494
|
)
|
|
Prepaid expenses
|
|
(2,891
|
)
|
|
(3,087
|
)
|
|
Other current assets
|
|
(4,722
|
)
|
|
886
|
|
|
Accounts payable and accrued expenses
|
|
11,459
|
|
|
(12,663
|
)
|
|
Deferred and other long-term liabilities
|
|
(1,012
|
)
|
|
910
|
|
|
Net cash provided by operating activities
|
|
41,012
|
|
|
30,079
|
|
|
|
|
|
|
Investing activities
|
|
|
|
Capital expenditures, gross
|
|
(20,886
|
)
|
|
(14,415
|
)
|
|
Proceeds from disposals of property and equipment
|
|
1,033
|
|
|
2,710
|
|
|
Proceeds from (payment for) acquisition, net of cash acquired
|
|
144
|
|
|
(511
|
)
|
|
Other
|
|
—
|
|
|
(4
|
)
|
|
Net cash used in investing activities
|
|
(19,709
|
)
|
|
(12,220
|
)
|
|
|
|
|
|
Financing activities
|
|
|
|
Net increase in borrowings (maturities of 90 days or less)
|
|
168
|
|
|
429
|
|
|
Proceeds from borrowings (maturities longer than 90 days)
|
|
349
|
|
|
3,843
|
|
|
Principal payments on debt
|
|
(13,500
|
)
|
|
(7,413
|
)
|
|
Cash dividends on common stock
|
|
—
|
|
|
(7,065
|
)
|
|
Other
|
|
(8,744
|
)
|
|
(1,787
|
)
|
|
Net cash used in financing activities
|
|
(21,727
|
)
|
|
(11,993
|
)
|
|
|
|
|
|
Effect of exchange rate changes on cash flows
|
|
1,594
|
|
|
2,045
|
|
|
Net increase in cash
|
|
1,170
|
|
|
7,911
|
|
|
Cash and cash equivalents at beginning of period
|
|
24,218
|
|
|
16,816
|
|
|
Cash and cash equivalents at end of period
|
$
|
25,388
|
|
$
|
24,727
|
|
|
Supplemental schedule of noncash investing and financing
activities:
|
|
|
|
|
|
|
|
Common stock issued in lieu of cash dividends pursuant to the
Dividend Reinvestment Plan
|
$
|
—
|
|
$
|
7,800
|
|
EBITDA is defined as net income (loss) before interest expense, income
tax provision (benefit) and depreciation and amortization. Adjusted
EBITDA is defined in our credit facility and is EBITDA plus (i) ,
restructuring or related impairment costs (not to exceed $12.0 million
in the aggregate for 2007 and $5.0 million in the aggregate in each year
thereafter, (ii) reserves for inventory in connection with plant
closings, (iii) stock-based and other non-cash compensation charges,
charges from forgiveness of loans made to employees in connection with
the purchase of equity and any tax gross-up payments made in respect of
such loan forgiveness in connection with or prior to the completion of
our initial public offering, (iv) certain transaction costs, including
costs incurred in connection with our initial public offering and the
related debt financing, the legal reorganization of Brazilian
subsidiaries and the preparation and closing of the existing credit
agreement, (v) consolidated amendment/termination costs, which consist
of costs incurred in connection with the consummation of the fourth and
fifth amendments to the senior credit facility and the termination of
the employment contract of the former Chief Executive Officer and
transition to the new Chief Executive Officer, not to exceed $8.0
million in the aggregate, (vi) costs associated with payments to
management prior to the completion of our initial public offering in
connection with the termination of incentive plans, (vii) non-cash
charges resulting from the application of purchase accounting, (viii)
non-cash expenses resulting from the granting of stock options,
restricted stock or restricted stock unit awards under equity
compensation programs solely with respect to our common stock and (ix)
expenses incurred not exceeding $7 million per year as a result of the
repurchase, redemption or retention of our own common stock earned under
equity compensation programs solely in order to make withholding tax
payments. For certain historical periods, the amended credit agreement
specified Adjusted EBITDA is $35,610, $36,514 and $38,431 for the
quarters ended March 31, 2008, December 31, 2007 and September 30, 2007,
respectively. For the quarter ended March 31, 2008, the amount reflects
an increase of $800 over the originally disclosed amount in the first
quarter of 2008 related to the transition to the new Chief Executive
Officer. Adjusted EBITDA, as defined in the credit facility and
calculated below, may not be comparable to similarly titled measurements
used by other companies. The following table provides reconciliation
from net cash provided by operating activities, which is the most
directly comparable GAAP financial measure, to EBITDA and Adjusted
EBITDA.
|
|
Three Months Ended
June 30,
|
|
(in thousands)
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
$
|
11,238
|
|
$
|
14,825
|
|
|
Interest expense, net
|
|
766
|
|
|
11,155
|
|
|
Net change in operating assets and liabilities
|
|
240
|
|
|
11,234
|
|
|
Income tax provision
|
|
1,911
|
|
|
4,604
|
|
|
Stock-based compensation
|
|
197
|
|
|
(660
|
)
|
|
Deferred financing cost amortization
|
|
(1,249
|
)
|
|
(900
|
)
|
|
Deferred taxes
|
|
2,251
|
|
|
(6,903
|
)
|
|
Asset impairment
|
|
(67
|
)
|
|
—
|
|
|
Gain on disposition of property and equipment
|
|
269
|
|
|
1,223
|
|
|
Unrealized foreign exchange gain on indebtedness, net
|
|
(509
|
)
|
|
20
|
|
|
Change in fair value of interest rate swaps
|
|
13,704
|
|
|
69
|
|
|
EBITDA
|
|
28,751
|
|
|
34,667
|
|
|
Unrealized foreign exchange gain on indebtedness, net (D)
|
|
—
|
|
|
(20
|
)
|
|
Amendment/termination costs (F)
|
|
5,198
|
|
|
—
|
|
|
Change in fair value of interest rate swaps (E)
|
|
13,704
|
|
|
—
|
|
|
Restructuring expenses
|
|
2,651
|
|
|
1,220
|
|
|
Non-cash impairment charges (A)
|
|
67
|
|
|
—
|
|
|
Growth program costs (B)
|
|
—
|
|
|
1,587
|
|
|
Inventory write-offs under restructuring programs
|
|
—
|
|
|
80
|
|
|
Non-cash compensation and related expenses
|
|
(197
|
)
|
|
660
|
|
|
Non-recurring expenses resulting from cost reduction programs (C)
|
|
—
|
|
|
34
|
|
|
Adjusted EBITDA
|
$
|
50,174
|
|
$
|
38,228
|
|
|
|
Six Months Ended June 30,
|
|
(in thousands)
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
Net cash provided by operating activities
|
$
|
41,012
|
|
$
|
30,079
|
|
|
Interest expense, net
|
|
25,987
|
|
|
23,342
|
|
|
Net change in operating assets and liabilities
|
|
(11,264
|
)
|
|
12,399
|
|
|
Income tax provision
|
|
5,550
|
|
|
6,005
|
|
|
Stock-based compensation
|
|
(274
|
)
|
|
(1,195
|
)
|
|
Deferred financing cost amortization
|
|
(2,344
|
)
|
|
(1,818
|
)
|
|
Deferred taxes
|
|
3,012
|
|
|
(5,780
|
)
|
|
Asset impairment
|
|
(67
|
)
|
|
(389
|
)
|
|
Gain on disposition of property and equipment
|
|
269
|
|
|
1,145
|
|
|
Unrealized foreign exchange gain on indebtedness, net
|
|
1,476
|
|
|
1
|
|
|
Change in fair value of interest rate swaps
|
|
1,548
|
|
|
(1,494
|
)
|
|
EBITDA
|
|
64,905
|
|
|
62,295
|
|
|
Unrealized foreign exchange gain on indebtedness, net (D)
|
|
(1,985
|
)
|
|
(1
|
)
|
|
Amendment/termination costs (F)
|
|
5,998
|
|
|
—
|
|
|
Change in fair value of interest rate swaps (E)
|
|
13,704
|
|
|
—
|
|
|
Change in fair value of other derivatives
|
|
(2,126
|
)
|
|
—
|
|
|
Restructuring expenses
|
|
3,183
|
|
|
4,964
|
|
|
Non-cash impairment charges (A)
|
|
67
|
|
|
389
|
|
|
Growth program costs (B)
|
|
1,764
|
|
|
2,204
|
|
|
Inventory write-offs under restructuring programs
|
|
—
|
|
|
94
|
|
|
Non-cash compensation and related expenses
|
|
274
|
|
|
1,195
|
|
|
Non-recurring expenses resulting from cost reduction programs (C)
|
|
—
|
|
|
(68
|
)
|
|
Adjusted EBITDA
|
$
|
85,784
|
|
$
|
71,072
|
|
|
|
|
|
|
(A) In accordance with the definition of Adjusted EBITDA in our
credit facility, non-cash impairment charges resulting from
application of Statement of Financial Accounting Standards Nos.
142 and 144 have been added back to Adjusted EBITDA.
|
|
|
|
|
|
(B) In accordance with the definition of Adjusted EBITDA in our
credit facility, as amended on May 30, 2008, growth program costs
are not added back to Adjusted EBITDA for periods beginning after
the quarter ended March 31, 2008. Prior to that period, growth
programs were added back to Adjusted EBITDA based upon the credit
facility agreement as in effect at that time. Growth programs were
those intended to increase productivity and economic efficiency or
the market share capacity of the Company, reduce cost structure,
improve equipment utilization or provide additional regional
capacity to better serve growth markets. These growth program
costs for the six months ended June 30, 2008 and for the three and
six months ended June 30, 2007 included expenses incurred for our
lean manufacturing initiatives, expansion into Vietnam and other
growth programs.
|
|
|
|
|
|
(C) In accordance with the definition of Adjusted EBITDA in our
credit facility, as amended on May 30, 2008, non-recurring
expenses resulting from cost reduction programs are not added back
to Adjusted EBITDA for periods beginning after the quarter ended
March 31, 2008. Prior to that period, cost reduction programs
were added back to Adjusted EBITDA based upon the credit facility
agreement as in effect at that time and were comprised of the
following:
|
|
(in thousands)
|
|
Three Months Ended June 30, 2008
|
|
Three Months Ended June 30, 2007
|
|
Six Months Ended June 30, 2008
|
|
Six Months Ended June 30, 2007
|
|
|
|
|
|
|
|
|
|
|
|
Environmental charges in connection with facilities closures
pursuant to cost reduction programs (1)
|
$
|
n/a
|
|
$
|
—
|
|
$
|
—
|
|
$
|
(200
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Certain operating costs incurred in connection with the transition
of production operations from closed facilities to other facilities
(2)
|
|
n/a
|
|
|
34
|
|
|
—
|
|
|
132
|
|
|
Total
|
$
|
n/a
|
|
$
|
34
|
|
$
|
—
|
|
$
|
(68
|
)
|
|
|
|
|
|
|
|
|
|
|
|
(1) For the six months ended June 30, 2007, reflects the reversal
of amounts accrued in prior periods.
|
|
|
|
(2) For the three and six months ended June 30, 2007, the amount
includes added operating costs related to facility closures in
Italy.
|
|
|
|
(D) In accordance with the definition of Adjusted EBITDA in our
credit facility, as amended on May 30, 2008, unrealized foreign
exchange gains and losses on indebtedness are not added back to
Adjusted EBITDA for periods beginning after the quarter ended
March 31, 2008. Prior to that period, such gains and losses are
added back to Adjusted EBITDA based upon the credit facility as in
effect at that time.
|
|
|
|
(E) In accordance with the definition of Adjusted EBITDA in our
credit facility agreement, as amended on May 30, 2008, interest
expense added back to calculate Adjusted EBITDA excludes, for
periods beginning after the quarter ended March 31, 2008, the
effect of any non-cash gains and losses resulting from the marking
to market of hedging obligations that has been charged to interest
expense. Had this amended definition been in place for all
periods presented, Adjusted EBITDA would have been $12.2 million
lower for the three and six months ended June 30, 2008,
respectively and $1.5 million lower for the six months ended June
30, 2007. Impact to the three months ended June 30, 2007 would
have been immaterial.
|
|
|
|
(F) For the three and six months ended June 30, 2008,
amendment/termination costs include $5,198 of costs incurred in
connection with the consummation of the fourth and fifth
amendments to the credit facility and for the six months ended
June 30, 2008, these costs include an $800 increase to Adjusted
EBITDA for the first quarter of 2008, in accordance with the
agreement with our lenders.
|
SBG Investor Relations
Geoffrey Buscher, 508-532-1790
IR@xerium.com